|
COGT Cogent Biosciences Inc 1622229 |
| Income Statement |
|
Net Income
|
2026-06-30
|
$-96,405,000.00 |
| Balance Sheet |
|
Current Assets
|
$804,820,000.00 |
|
Assets
|
$834,546,000.00 |
|
Current Liabilities
|
$59,296,000.00 |
|
Liabilities
|
$302,158,000.00 |
|
Equity
|
$532,388,000.00 |
|
Shares Out
|
171598409.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-164,154,000.00 |
|
Investing Cash Flow
|
$-22,177,000.00 |
| Market Analysis |
Market Cap
|
$6,059,139,821.79 |
|
Price
|
$35.31 |
|
BVPS
|
3.10 |
|
PB
|
11.39 |
|
EPS
|
-0.52 |
|
FCF
|
$-164,973,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:22 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:14 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view COGT documents filed with the SEC.
COGT Filings
Clear
